文献速递免疫规划

辐射减毒、化学减毒和遗传减毒伯氏疟原虫子孢子疫苗提供的长期保护作用存在差异

Variable long-term protection by radiation-, chemo-, and genetically-attenuated Plasmodium berghei sporozoite vaccines.
PubMed 文献 · Vaccine · 2023-11-25

该研究在小鼠疟疾模型中比较了辐射减毒子孢子(RAS)、早期和晚期阻滞遗传减毒子孢子(EA-GAP和LA-GAP)以及化学预防子孢子(CPS)四种全子孢子疫苗在36周内的保护持久性。结果显示EA-GAP保护最低,RAS和LA-GAP保护最持久,CPS保护迅速减弱,尤其在较高免疫剂量下;CPS免疫小鼠肝脏CD44hi CD8+ T细胞PD-1和LAG-3表达增加,提示耗竭表型。作者认为需在人体中详细比较不同全子孢子疫苗的保护持续时间。

要点

  • 小鼠模型中EA-GAP全子孢子疫苗对感染性伯氏疟原虫攻击的总体保护最低。
  • RAS和LA-GAP免疫诱导最持久的保护,CPS保护在36周内迅速减弱,高剂量时尤其明显。
  • CPS免疫小鼠肝脏CD44hi CD8+ T细胞PD-1和LAG-3表达增加,提示记忆CD8+ T细胞耗竭表型。

核心结论

  • 小鼠模型中RAS和LA-GAP全子孢子疫苗保护最持久,EA-GAP保护最低,CPS保护在36周内迅速减弱。
  • CPS免疫小鼠肝脏CD44hi CD8+ T细胞PD-1和LAG-3表达增加,提示耗竭表型可能解释保护快速减弱。
  • 作者认为需在人体中详细比较不同全子孢子疫苗配方的保护持续时间,并提示RAS和LA-GAP可能优于EA-GAP或CPS。

研究设计与样本

  • 采用小鼠疟疾模型,评估基于伯氏疟原虫(Pb)的四种全子孢子疫苗类似物免疫后36周内的保护作用。

主要发现

  • EA-GAP全子孢子疫苗对感染性Pb攻击的总体保护最低。
  • RAS和LA-GAP免疫诱导最持久的保护。
  • CPS全子孢子疫苗的保护效力在36周内迅速减弱,尤其在较高免疫剂量下更明显。
  • CPS免疫小鼠肝脏CD44hi CD8+ T细胞PD-1和LAG-3表达水平较其他全子孢子疫苗免疫小鼠增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Long-term protection against malaria remains one of the greatest challenges of vaccination against this deadly parasitic disease. Whole-sporozoite (WSp) malaria vaccine formulations, which target the Plasmodium parasite's pre-erythrocytic stages, include radiation-attenuated sporozoites (RAS), early- and late-arresting genetically-attenuated parasites (EA-GAP and LA-GAP, respectively), and chemoprophylaxis with sporozoites (CPS). Although all these four vaccine formulations induce protective immune responses in the clinic, data on the longevity of the antimalarial protection they afford remain scarce. We employed a mouse model of malaria to assess protection conferred by immunization with P. berghei (Pb)-based surrogates of these four WSp formulations over a 36-week period. We show that EA-GAP WSp provide the lowest overall protection against an infectious Pb challenge, and that while immunization with RAS and LA-GAP WSp elicits the most durable protection, the protective efficacy of CPS WSp wanes rapidly over the 36-week period, most notably at higher immunization dosages. Analyses of liver immune cells show that CD44hi CD8+ T cells in CPS WSp-immunized mice express increased levels of the co-inhibitory PD-1 and LAG-3 markers compared to mice immunized with the other WSp formulations. This indicates that memory CD8+ T cells elicited by CPS WSp immunization display a more exhausted phenotype, which may explain the rapid waning of protection conferred by the former. These results emphasize the need for a detailed comparison of the duration of protection of different WSp formulations in humans and suggest a more beneficial effect of RAS and LA-GAP WSp compared to EA-GAP or CSP WSp.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Moita D, Nunes-Cabaço H, Rôla C, et al. Variable long-term protection by radiation-, chemo-, and genetically-attenuated Plasmodium berghei sporozoite vaccines. Vaccine. 2023. PMID: 38007342. doi:10.1016/j.vaccine.2023.11.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。